THE PPM1D ENCODED PHOSPHATASE WIP1 IS A NOVEL ONCOGENE AND POTENTIAL THERAPEUTIC TARGET IN NEUROBLASTOMA AND MEDULLOBLASTOMA

被引：0
|
作者：
Milosevic, J. [1 ]
Treis, D. [1 ]
Malin, M. [1 ]
Fransson, S. [2 ]
Sveinbjornsson, B. [3 ]
Eissler, N. [1 ]
Baryawno, N. [1 ]
Tanino, K. [4 ]
Selivanova, G. [5 ]
Sakaguchi, K. [4 ]
Martinsson, T. [2 ]
Johnsen, J. I. [1 ]
Kogner, P. [1 ]
机构：
[1] Karolinska Inst, Womens & Childrens Hlth, Stockholm, Sweden
[2] Gothenburg Univ, Dept Clin Genet, Inst Biomed, Gothenburg, Sweden
[3] Univ Tromso, Div Immunol IMB, Tromso, Norway
[4] Hokkaido Univ, Fac Sci, Biol Chem Lab, Dept Chem, Sapporo, Hokkaido 060, Japan
[5] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden
来源：
PEDIATRIC BLOOD & CANCER | 2015年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-382
引用
收藏
页码：S332 / S332
页数：1
相关论文
共 50 条
  • [31] Phosphatase magnesium-dependent 1 δ (PPM1D), serine/threonine protein phosphatase and novel pharmacological target in cancer
    Nahta, Rita
    Castellino, Robert Craig
    BIOCHEMICAL PHARMACOLOGY, 2021, 184
  • [32] Phosphatase Wip1 as a new therapeutic target for intestinal ischemia-reperfusion injury
    Shen, Xiaofei
    Du, Junfeng
    Zhao, Yong
    Guan, Wenxian
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2014, 10 (12) : 1591 - 1595
  • [33] Smaller protein, larger therapeutic potential: PPM1D as a new therapeutic target in brainstem glioma
    Reitman, Zachary J.
    PHARMACOGENOMICS, 2014, 15 (13) : 1639 - 1641
  • [34] PPM1D/Wip1 expression is increased in prostate carcinoma with high Gleason score and is regulated by the androgen mitogen.
    Festa, Fernanda
    Gomes, Luciana Rodrigues
    Rodrigues, Leonardo De Oliveira
    Flatschart, Aurea Vf
    Mahler-Araujo, Maria Betania
    Carraro, Dirce Maria
    Reis, Luis Fernando
    Sarkis, Alvaro S.
    Soares, Fernando F.
    Brentani, Ricardo R.
    Reis, Eduardo M.
    Verjovski-Almeida, Sergio
    Sogayar, Mari Cleide
    CANCER RESEARCH, 2006, 66 (08)
  • [35] PPM1D is a prognostic marker and therapeutic target in colorectal cancer
    Peng, Tian-Shu
    He, Yong-Heng
    Nie, Tian
    Hu, Xiang-Dang
    Lu, Hai-Yan
    Yi, Jian
    Shuai, Yun-Fei
    Luo, Min
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2014, 8 (02) : 430 - 434
  • [36] PPM1D inhibition may allow us to WIP leukemia
    Marcellino, Bridget K.
    BLOOD, 2023, 142 (24)
  • [37] Gain-of-function mutations of PPM1D/Wip1 impair the p53-dependent G1 checkpoint
    Kleiblova, Petra
    Shaltiel, Indra A.
    Benada, Jan
    Sevcik, Jan
    Pechackova, Sona
    Pohlreich, Petr
    Voest, Emile E.
    Dundr, Pavel
    Bartek, Jiri
    Kleibl, Zdenek
    Medema, Rene H.
    Macurek, Libor
    JOURNAL OF CELL BIOLOGY, 2013, 201 (04): : 511 - 521
  • [38] Wip1 as a therapeutic target for high-grade gliomas
    Seoane, Marcos
    Iglesias, Pablo
    Gonzalez, Teresa
    Fraga, Maximo
    Aliste, Carlos
    Dominguez, Fernando
    Forteza, Jeronimo
    Costoya, Jose A.
    CANCER RESEARCH, 2009, 69
  • [39] Increased wild-type p53-induced phosphatase 1 (Wip1 or PPM1D) expression correlated with downregulation of checkpoint kinase 2 in human gastric carcinoma
    Fuku, Takeichi
    Semba, Shuho
    Yutori, Hirokazu
    Yokozaki, Hiroshi
    PATHOLOGY INTERNATIONAL, 2007, 57 (09) : 566 - 571
  • [40] WIP1 is a novel specific target for growth hormone action
    Apaydin, Tugce
    Zonis, Svetlana
    Zhou, Cuiqi
    Valencia, Christian Wong
    Barrett, Robert
    Strous, Ger J.
    Mol, Jan A.
    Chesnokova, Vera
    Melmed, Shlomo
    ISCIENCE, 2023, 26 (11)
12345